Spinal muscular atrophy approval boosts antisense drugs.
Elie
E
Dolgin
D017277:Drug Approval; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence; D006801:Humans; D009134:Muscular Atrophy, Spinal / Q000188:drug therapy*; D016376:Oligonucleotides, Antisense / Q000191:economics / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
D016376:Oligonucleotides, Antisense